| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.15B | 14.09B | 14.54B | 14.66B | 14.85B | 12.52B |
| Gross Profit | 5.31B | 4.68B | 5.51B | 5.60B | 5.72B | 5.29B |
| EBITDA | 6.47B | 5.87B | 7.07B | 7.27B | 7.59B | 7.09B |
| Net Income | 3.05B | 2.89B | 3.47B | 3.67B | 4.11B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 44.23B | 43.68B | 42.76B | 42.21B | 41.91B | 40.53B |
| Cash, Cash Equivalents and Short-Term Investments | 1.11B | 675.00M | 1.00B | 1.44B | 2.09B | 2.32B |
| Total Debt | 19.34B | 19.35B | 18.99B | 19.02B | 18.54B | 16.84B |
| Total Liabilities | 30.65B | 30.52B | 30.26B | 30.23B | 29.29B | 27.03B |
| Stockholders Equity | 13.57B | 13.16B | 12.50B | 11.98B | 12.63B | 13.50B |
Cash Flow | ||||||
| Free Cash Flow | 4.13B | 1.71B | 2.72B | 3.26B | 3.49B | 3.31B |
| Operating Cash Flow | 4.63B | 4.61B | 5.25B | 5.51B | 5.62B | 5.10B |
| Investing Cash Flow | -2.77B | -2.85B | -2.60B | -2.23B | -2.13B | -1.88B |
| Financing Cash Flow | -2.03B | -2.02B | -3.06B | -3.87B | -3.77B | -4.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $45.82B | 32.15 | 24.03% | 0.71% | -5.48% | -11.72% | |
77 Outperform | C$95.81B | 16.73 | 21.95% | 2.62% | 1.51% | 7.91% | |
73 Outperform | $84.38B | 23.65 | 23.52% | 1.42% | -0.92% | -2.64% | |
70 Outperform | C$106.58B | 22.36 | 8.90% | 0.82% | 3.66% | 13.45% | |
70 Outperform | $78.27B | 29.49 | 17.43% | 1.85% | 0.60% | ― | |
65 Neutral | $159.53B | 21,145.45 | 41.95% | 2.32% | 1.87% | 9.41% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |